Step by Stepa HemeOncBuddy patient portal

Dostarlimab

Illustration: Dostarlimab

Say it: doh-STAR-lih-mab · Brand names: Jemperli

Dostarlimab is an immunotherapy medicine that helps your own immune system fight cancer.

What it is

Cancer cells can hide from the immune system by pressing a brake called PD-1 on immune cells. Dostarlimab blocks this brake. This helps your immune system find and attack the cancer.

Often used for

How you get it

Dostarlimab is given through a vein (IV) in a clinic. The infusion takes about 30 minutes. It is often given every 3 weeks at first, then every 6 weeks. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Dostarlimab?
Dostarlimab is an immunotherapy medicine that helps your own immune system fight cancer. Brand names: Jemperli.
What is Dostarlimab used for?
endometrial cancer (cancer of the lining of the uterus); and some other cancers with certain tumor test results.
How is Dostarlimab given?
Dostarlimab is given through a vein (IV) in a clinic. The infusion takes about 30 minutes. It is often given every 3 weeks at first, then every 6 weeks. Your schedule may be different.
What are the common side effects of Dostarlimab?
Feeling tired. Rash or itchy skin. Diarrhea. Muscle or joint aches. Not feeling hungry. Upset stomach.
When should I call my care team while taking Dostarlimab?
Diarrhea, belly pain, or bloody or black stools; A new or worse cough, chest pain, or shortness of breath; Yellow skin or eyes, very dark pee, or pain on the right side of the belly; Bad headache, extreme tiredness, dizziness, or feeling very cold or very hot; Feeling very thirsty, peeing a lot, or confusion (signs of high blood sugar); Chest pain, a fast or uneven heartbeat, or muscle weakness; A rash with blisters, peeling skin, or sores in the mouth.
Which chemotherapy plans include Dostarlimab?
Carboplatin and paclitaxel.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.